SICHENZIA ROSS FRIEDMAN FERENCE LLP
                  1065 AVENUE OF THE AMERICAS NEW YORK NY 10018
               TEL 212 930 9700 FAX 212 930 9725 WEB WWW. SRFF.COM

June 30, 2005

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549-0405

         Attention:        Reginald A. Norris, Esq.
                           Mail Stop 0407

         Re:      Walker Financial Corporation (the "Company")
                  Amendment No. 1 to Form SB-2
                  File No. 333-122776
                  Filed February 11, 2005

                  Form 10-KSB for the year ended December 31, 2003
                  Forms 10-QSB for the quarter ended September 30, 2004
                  File No. 0-28173

Dear Mr. Norris:

On behalf of the Company,  we are hereby enclosing two copies of Amendment No. 1
(the  "Amendment")  to the  Company's  registration  statement on Form SB-2 (the
"Registration  Statement").  One of the copies has been  marked to show  changes
from  the  Registration  Statement.  The  Registration  Statement  was  filed on
February 11, 2005. By letter dated March 11, 2005,  the staff of the  Securities
and  Exchange  Commission  (the  "Staff")  issued  comments on the  Registration
Statement and the Form 10-QSB for the three months ended September 30, 2004 (the
"Form  10-QSB")  and the Form 10-KSB for the year ended  December  31, 2004 (the
"Form  10-KSB")  (Commission  File No.  0-13215).  Following  are the  Company's
responses  to the Staff's  comments.  For ease of  reference,  each  response is
preceded by the Staff's comment.

In its letter,  the Staff  requested that the Company make certain  revisions to
its Form  10-QSB.  As noted in our  responses  to  comments  49 through  52, the
Company  intends  to file  amendments  to the Form  10-QSB  and,  to the  extent
required,  to  the  Form  10-KSB  upon  clearing  the  Staff's  comments  on the
Registration Statement.

General

1.   The  financial  statements  and MD&A and should be updated to December  31,
     2004,  as required by Rule l-l0(g) of Regulation  S-B. In addition,  please
     update your other  disclosure where required (e.g.  executive  compensation
     information).



     The financial  statements  and MD&A have been updated to March 31, 2005. In
     addition,  per the  requirements  of Rule  1-10(g) of  Regulation  S-B, the
     Company has updated its disclosures as required.

2.   Please  note that  companies  do not  "list"  their  securities  on the OTC
     Bulletin Board.  Brokers must apply to the to quote a company's  securities
     on the OTC Bulletin  Board.  Therefore,  revise the reference to your stock
     being listed on the OTC Bulletin Board.

     The Company has revised the  Registration  Statement in accordance with the
     Staff's comment.

Prospectus Summary, Overview, page 5

3.   As  currently  drafted,  the  description  of your  business  is vague  and
     contains industry jargon that does not provide any meaningful  information.
     For  example,  what do you  mean  that  you  provide  "prearrangement"  and
     "pre-need  products?" Also, what does it mean that you have  "established a
     worksite  and affinity  marketing  strategy?"  Instead of this  disclosure,
     simply state, if true, that you sell funeral plans to individuals on behalf
     of funeral companies.  In addition,  in light of your financial history and
     condition,  it is unclear the nature and extent of your  current and future
     operations.  Please revise to discuss what  products/services you currently
     provide,  the extent of those operations to date, and how you provide these
     operations.  In addition, please discuss what product/service you intend to
     provide as well as status of that  product/service  in development.  Revise
     your entire document,  including this section,  your Business section,  and
     your MD&A, so that ordinary  investors have a clear  understanding  of what
     you do and the goods and services that you sell and how you sell them.

     The Company has revised this disclosure to provide a clearer description of
     its  business  and  industry.  The  Company has also  revised its  business
     description   to  discuss   its  current   and  future   operations,   what
     products/services it currently provides,  the extent of those operations to
     date, and how it provides these  operations.  In addition,  the Company has
     added disclosure  describing the products/services it intends to provide as
     well as status of those products/services that are in development.

4.   Further,  as part of your revisions,  please continue to provide a balanced
     picture of your  operations,  financial  condition,  and structure.  Please
     disclose  that you have an  accumulated  deficit of $4.1  million  and only
     recently entered into your current business. In addition, disclose that you
     need $1 million to fund your operations for the next twelve months.

     The Company has revised the Registration  Statement to disclose that it has
     an  accumulated  deficit of $6.1 million and that it only recently  entered
     into its current business. In addition, the Company has added disclosure to
     the effect  that it needs $1 million  to fund its  operations  for the next
     twelve months.

5.   In this regard,  please revise  throughout the prospectus where appropriate
     to discuss your corporate  history  including when and how you entered into
     your current business.

     The Company has revised  throughout  the  prospectus  where  appropriate to
     discuss its corporate  history  including  when and how it entered into its
     current business.

Risk Factors, Page 6

6.   Please delete the second and third sentences of the introductory paragraph.
     Once you describe all material risks,  and tailor each one to your specific
     facts and circumstances,  you will not need this generic,  boilerplate risk
     disclosure.


                                       2


     The Company has deleted the second and third sentences of the  introductory
     paragraph.

7.   Please  revise each risk factor  caption so that it reflects  the risk that
     you discuss in the text.  Currently,  many of your risk factor captions are
     unduly vague,  such as "We have a limited  operating  history with which to
     judge our performance" on page 3, or merely state a fact about you, such as
     "Our auditors have recognized a material weakness in our internal controls"
     on page 4.  Others  captions  simply  allude  to a  future  event,  such as
     "Changes or increases in, or failure to comply with, regulations applicable
     to our  business  could  increase  our  costs"  on page 5.  These  are only
     examples.  Revise throughout to identify briefly in your captions the risks
     that result from the facts or uncertainties.  Potential investors should be
     able to read the risk factor  captions and come away with an  understanding
     of what the risk is and the result of the risk as it  specifically  applies
     to you. As a general rule,  your revised  captions should work only in this
     document.  If they are readily transferable to other companies'  documents,
     they are probably too generic. Please revise accordingly.

     The Company has revised  each risk factor  caption so that it reflects  the
     risk that is discussed in the text.

8.   Please avoid the generic conclusion in the captions and discussions that if
     a risk occurs your  business and results of  operations  could be adversely
     affected  or  substantially  harmed.  This  does not  represent  meaningful
     disclosure.  Instead, replace this language with specific disclosure of the
     possible  impact upon your operating  results,  business,  liquidity,  cash
     flow, financial condition, share price, etc.

     The Company has replaced  this  language in the risk factors with  specific
     disclosure  of the possible  impact upon its operating  results,  business,
     liquidity, cash flow, financial condition and share price.

Our auditors have recognized a material weakness ..., page 4

9.   Please provide more disclosure regarding the risk to you and your investors
     resulting  from your  auditors  identifying  a  material  weakness  in your
     internal  controls.  In this regard,  we note your statement on page 4 that
     management  "believes  that  sufficient  compensating  controls  have  been
     implemented to minimize the risks associated with this material  weakness."
     Please delete this disclosure as mitigating  language is not appropriate in
     the risk factor section.

     The Company has provided more  disclosure  regarding the risk to it and its
     investors  resulting from its auditors  identifying a material  weakness in
     the Company's internal controls.

Increased advertising or better marketing by our competitors, page 5

10.  To the extent possible, please quantify your market share in the industry.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Changes or increases in, or failure to comply with, regulations.... page 5

11.  Please  provide  more  disclosure  how this  risk may  affect  you and your
     investors.  For example,  are you in compliance  with all applicable  laws?
     Have you incurred any costs due to these laws?


                                       3


     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

If we fail to remain current on our reporting requirements. .. page 7

12.  In order for investors to understand the likelihood of this risk occurring,
     please disclose whether you have been delinquent in your periodic reporting
     during the last twelve months.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Forward Looking Statement, page 9

13.  Please  delete your  reference to Section 27A and Section 21E as these safe
     harbors do not apply to any issuer who has issued penny stock.  See Section
     27A(b)(1)(C) of the Securities Act of 1933 and Section  21E(b)(l)(C) of the
     Securities Exchange Act of 1934.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Management's Discussion and Analysis..., Overview, page 11

14.  Please revise this section to highlight the most important  developments of
     the period being reported  without being  repetitive of or summarizing  the
     ensuing MD&A discussion. This discussion should be written in Plain English
     from the CEO's perspective, focusing on issues "that keep him up at night."
     Such topics could include:

               o    economic or industry-wide factors relevant to the company;

               o    how the  company  earns  revenues  and income and  generates
                    cash;

               o    the company's lines of business, locations of operations and
                    principal  products and services without being repetitive of
                    the  Business   section  or  disclosure   elsewhere  in  the
                    prospectus; and

               o    the  material  opportunities,   challenges  and  risks  that
                    management  are most focused on for the short and long term,
                    as well as actions  that they are  taking to  address  these
                    opportunities,  challenges and risks.  For example,  we note
                    your  disclosure  on  page  13  that  National   Preplanning
                    "expects to start achieving more substantial revenues in the
                    second quarter of 2005." Your overview should  highlight why
                    management expects revenues to increase substantially in the
                    second quarter of 2005.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

15.  Please  discuss  any future  plans to expand  our  services  and  offerings
     including a discussion of the funding and timing  requirements  to complete
     any expansions for each subsidiary.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.


                                       4


16.  We note that your  auditors  cited a  material  weakness  in your  internal
     control over financial  reporting for the period ended  September 20, 2004.
     Please  revise this section to discuss any  potential  material  impacts on
     your  financial  condition  related  to the  weaknesses  in  the  company's
     internal control over financial reporting.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Critical Accounting Policies, page 11

17.  We note that your discussion of your critical accounting policies basically
     repeats  the  discussion  of  your  accounting  policies  in note 1 to your
     financial  statements.  Please  note that this is not the  purpose  of this
     disclosure.  This section  should only  highlight  accounting  estimates or
     assumptions where:

     o    the nature of the  estimates  or  assumption  is  material  due to the
          levels of  subjectivity  and judgment  necessary to account for highly
          uncertain matters or the susceptibility of such matters to change; and

     o    the impact of the estimates and assumptions on financial  condition or
          operating performance is material.

     Such  disclosures  should  supplement,  not duplicate,  the  description of
     accounting policies required in the notes to the financial statements.  The
     accounting policy note to the financial  statements generally describes the
     method  used to apply an  accounting  principle  while the MD&A  disclosure
     should  present a  company's  analysis  of the  uncertainties  involved  in
     applying  a  principle  at the  current  time  or the  variability  that is
     reasonably  likely to result from its application over time.  Please revise
     accordingly.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Results of Operations...page 13

18.  Throughout this subsection,  you frequently  attribute a material change to
     two or more events or factors that you describe without quantification.  In
     discussing  the  material  changes,  please  quantify  the amount of change
     attributed  to  each  factor.  For  example,   operating  expenses  were  a
     significant  reason for your net loss for the nine months  ended  September
     30, 2004; however, there is no detail as to how much each component of your
     operating expenses (new employee hires,  website  development and marketing
     costs)  contributed  to the overall  increase from the  comparable  earlier
     period. Refer to Item 303 of Regulation S-B.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

19.  Also, in this regard,  please provide  disclosure that will provide insight
     into the underlying  business  developments  or conditions that resulted in
     the changes. Discuss whether any of these factors represent part of a trend
     that will continue to affect your  operations  going forward.  For example,
     how do you  expect  competing  with  larger  and more  established  funeral
     companies will impact you as you commence and expand  operations.  See Item
     303(b)(1)(iv) of Regulation S-B.


                                       5


     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

20.  Please  disclose why your net sales for the nine months ended September 30,
     2004  decreased so much from  $505,098 for the nine months ended  September
     30, 2003. In your explanation, please discuss the extent to which change in
     revenues was attributable to changes in volume versus changes in price.

     All financial disclosures in the Registration  Statement have been updated.
     As a result,  the  Company  does not  believe  that this  specific  comment
     requires a revision.

21.  Please  provide  more  detail on your  history of net  losses.  Discuss the
     company,  industry or other events or trends that  contributed  to your net
     losses and discuss  whether and how you expect  these  trends and events to
     continue to affect you in the future

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

22.  Please revise the  presentation of statement of operations on pages F-3 and
     F-21, to disclose  separate  line items for operating  expenses and selling
     and general and administrative expenses

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

23.  In the last  paragraph  of the  Results  of  Operations  for the year ended
     December 31, 2003 as compared to December 31, 2002, there is a reference to
     cash and cash  equivalents  derived  from  "Walker."  Please  explain  this
     reference.

     All financial disclosures in the Registration  Statement have been updated.
     As a result,  the  Company  does not  believe  that this  specific  comment
     requires a revision.

Liquidity and Capital Resources...page 25

24.  In addition,  to the extent known,  please  quantify your expected  capital
     expenditures to fund and expand your business for the next twelve months.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

25.  Your  discussion of net cash provided by financing is difficult to read due
     to the amount of detailed disclosure you provide.  Revise this paragraph to
     individually identify each source of financing you received during 2004 and
     disclose the material terms of each source of financing.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

26.  In this regard, please discuss the extent to which you have relied on loans
     and  advances  from company  insiders as well as from  private  placements.
     Quantify the amount of funds you have  received  from these sources for the
     past twelve months.


                                       6


     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

27.  Please  quantify  your  obligation  to the  current  holders  of  your  10%
     promissory  notes due to your  failure to register  the  underlying  common
     stock and your default under the notes. Please advise whether your defaults
     under the indenture  create a risk to investors  that should be highlighted
     in the risk factors  section.  Advise whether any of the shares  underlying
     the convertible  notes are being registered for resale on this registration
     statement.

     The Company has quantified its obligation to the current holders of the 10%
     promissory notes due to its failure to register the underlying common stock
     and its default  under the notes.  The Company has also added a risk factor
     that the  defaults  under the  indenture  create a risk to  investors  that
     should be highlighted in the risk factors section.  The Company advises the
     Staff that it is registering  2,938,890 of the 3,121,600 shares  underlying
     the convertible notes for resale under the Registration Statement.

Plan of Operations, page 15

28.  Please  clarify what you mean by the statement  that  National  Preplanning
     "continues its  affiliation"  with eight funeral homes in New Jersey.  Does
     National  Preplanning  have a  contractual  arrangement  with these funeral
     homes? Revise your Business section as well.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Description of Business, General, page 27

29.  This  section  is  difficult  to read due to your use of  vague  terms  and
     industry jargon.  For example,  we note your disclosure on page 20 that you
     partner with  "beneficial  administration  firms." What does this mean?  As
     another  example,  you  state  on page 20 that  your  products  include  an
     "inflation  rider."  What is this and how does it make your  products  more
     favorable  than others  without an  inflation  rider?  You must revise this
     entire  section to delete vague terms and  industry  jargon and describe in
     simple clear language what specific products  /services you provide and how
     you provide them.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

30.  Please provide more disclosure  throughout  this section  regarding how you
     create and market death care financial service products. Please discuss how
     you procure your  arrangements  with  funeral  homes.  In addition,  please
     characterize  the nature of these  "arrangements."  Revise  throughout this
     section to clarify,  if true,  that you do not provide death care services,
     rather you package death care  services  provided by other parties and sell
     those  services  to the  public.  Furthermore,  what do you  mean  that you
     establish "strategic  partnerships with firms that will become distribution
     channels for the prearrangement  products?" In this regard,  please provide
     more detail regarding your distribution process.  Also, please explain more
     fully  how  insurance   companies  and  insurance   agents  assist  in  the
     provisioning of your products/services. Do you seek out insurance companies
     to  underwrite  policies for your death care  packages?  How can  insurance
     agents distribute your products?

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.


                                       7


31.  Please clarify,  if true, that once you have sold a death care package to a
     customer,  the customer has the option of financing the package through the
     purchase of insurance or through placing funds in a trust that you manage.

     The Company has  clarified  that once it has sold a death care package to a
     customer,  the customer  does not have the option of financing  the package
     through the purchase of insurance or through  placing funds in a trust that
     the Company manages.

32.  Please provide your basis for the following statements:

     o  "National  Preplanning.  . .  began  to  achieve  operating  results  by
     positioning  itself as one of the first  movers and  leaders in the sale of
     funeral pre-arrangements...," page 16

     o "12% of American  workers are current caring for an older person and this
     figure is expected to grow in the next few years...," page 19

     o "The death care industry is  projecting  over $17 billion in revenues for
     2004,  with over 5 billion  derived from the  prearrangement  of death care
     services...," page 20

     o "The United State Bureau of the Census also  projects  that the number of
     deaths in the U.S. will increase by one percent per year,  from 2.4 million
     to 2.6 million in 2010...," page 20

     o "This generation includes 78 million Americans born between 1946 and 1965
     and represents nearly 30% of the total U.S. population..." page 20

     The Company has removed those  statements that it believes are not relevant
     to investors and has included citations in the prospectus for the remaining
     statements.

Benefits Delivery Companies, page 20

33.  Please disclose who RewardsPlus is and whether you have an arrangement with
     them to offer your products/services.

     The Company has removed Rewards Plus from the prospectus as it is no longer
     relevant to its business.

Competition, page 21

34.  Please revise this section to discuss how you compete  within your industry
     despite  having  limited  operations  and assets.  In this  regard,  please
     discuss your  competition's  advantages  over you and discuss how this will
     affect your competitive position within the industry.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Employees, page 22

35.  Describe the material terms of your consulting agreements.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.


                                       8


Executive Compensation, page 25

36.  As a result of the  discontinuation  of Kelly  Color's  operations  and the
     statement  that Mr.  Walker is no longer an employee  of the company  (page
     23),  please  confirm  that  Mr.  Walker's  employment  agreement  has been
     terminated  and  revise  the  disclosure  to  confirm  that he is no longer
     considered  an  employee.  if this is not the case,  explain how lie can be
     considered  a  non-employee   director.   Revise  the  description  of  his
     employment agreement to confirm that the agreement has been terminated.

     Mr. Walker's  employment  agreement has not been  terminated.  He currently
     serves as an employee director.

Certain relationships and Related Transactions, page 27

37.  Please  update this section to discuss the material  terms of all financing
     and loan arrangements with your president and any other insiders.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Security Ownership of Certain Beneficial Owners and Management, page 28

38.  Please  disclose who retains voting and investment  control over the shares
     held by Fusion Capital Fund.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Description of Securities, page 29

39.  Please include a description of your  convertible  securities in compliance
     with Item 202(c) of Regulation S-B, including conversion prices, expiration
     dates, etc.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Se1ling Stockholders, page 32

40.  Please  disclose who retains voting and investment  control over the shares
     held by  Adkins & Co.,  J & V  Services,  Strategic  Growth  International,
     Pisces  Partners,  RS  &  VS  Ltd.,  Sybesma  Research  Corp.,  Reese  Cole
     Partnership, and Phoenix Holding LLC.

     The Company has made revisions to the Registration  Statement in accordance
     with the Staff's comment.

Financial statements

Consolidated statements of stockholders' equity, page F-4

41.  We note that some  issuances  of shares have not been  disclosed in Note 9.
     Also,  disclose  and tell us how you valued each share  issued for non-cash
     consideration,  including the market price used and  assumptions  you used.
     Please revise Note 9 on page F-15 and Item 26 of the Form SB-2


                                       9


     All financial disclosures in the Registration  Statement have been updated.
     As a result,  the  Company  does not  believe  that this  specific  comment
     requires a revision.

Consolidated statements of cash flows, page F-5

42.  Please consider  disclosing in the notes to the financial  statements,  the
     information  about non-cash issuance of equity securities during the fiscal
     years ended December 31, 2003 and December 31, 2002 in the amended  filing.
     Refer to paragraph 32 to SFAS no. 95.

     All financial disclosures in the Registration  Statement have been updated.
     As a result,  the  Company  does not  believe  that this  specific  comment
     requires a revision.

Notes to the consolidated financial statements

Note 1. Merger and organization of entities, page F-6

43.  We note that in second  paragraph  that ADS was issued  1,839,840 of common
     shares,  while in fifth  paragraph you indicate that ADS was issued 183,984
     shares of Walker's  common stock.  it appears to us that you have not given
     effect to the stock split  which was  declared  in  December  2002.  Please
     revise.

     The Company advises the Staff  supplemently that as a result of an error no
     effect  was given to a stock  dividend  of nine  shares  for each one share
     outstanding  that was declared in December 2002.  This  disclosure has been
     deleted  from the  Registration  Statement  as it  pertains  to a financial
     period no longer required to be disclosed.

44.  We note in Note 1, that in order to determine  the fair value of the assets
     and liabilities acquired in the merger transactions, you have used $2.69 as
     fair value of the common  stock of  Walker.  Also,  we note that the merger
     agreements were dated March 19, 2002.  Based on the  information  presented
     under Item 5 of the Form 10-KSB for the year ended  December 31, 2002,  the
     market  price of the  common  stock of Walker  was  approximately  $.30 per
     share.  Please  explain in detail  your basis to support  the fair value of
     $2.69 used in the  computation  of the purchase price of Walker and ADS. We
     may have further comments after review of your response.

     The Company advises the Staff  supplemently that as a result of an error no
     effect  was given to a stock  dividend  of nine  shares  for each one share
     outstanding  that was declared in December 2002.  This  disclosure has been
     deleted  from the  Registration  Statement  as it  pertains  to a financial
     period no longer required to be disclosed.

Recent sales of unregistered securities, page II-2

45.  Please refer to the  disclosures  provided on page F-4 and Item 26 - Recent
     sales of unregistered  securities on page II-2. For each issuance of shares
     and warrants disclose in the notes to the financial  statements both in the
     aggregate  and per share or option  price,  along with the  amounts of each
     form of consideration received.  Also, separately disclose each issuance of
     options or warrants, along with their terms

     All financial disclosures in the Registration  Statement have been updated.
     As a result,  the  Company  does not  believe  that this  specific  comment
     requires a revision.


                                       10


Exhibits

46.  Advise why you have not filed National  Preplanning's third party sales and
     marketing agreement with Stewart  Enterprises,  Inc. and strategic pre-need
     sales and marketing agreement with Hilb Rogal & Hobbs Insurance Services of
     Northern California as material agreements.

     The Company advises the Staff that it has not filed National  Preplanning's
     third party sales and marketing  agreement with Stewart  Enterprises,  Inc.
     and  strategic  pre-need  sales and marketing  agreement  with Hilb Rogal &
     Hobbs  Insurance  Services of Northern  California  as material  agreements
     because the Company has not yet achieved any  revenues in  connection  with
     them

Exhibit 5.1

47.  Revise the legality opinion to identify the appropriate state law which the
     opinion is based on.

     The legality opinion has been revised to state that it is based on Delaware
     law.

                        Form 10-KSB for December 31, 2003

48.  We  note  your   disclosure  in  this  section  that  there  have  been  no
     "significant  changes" in your internal  controls that could  significantly
     affect those  controls  since the most recent  evaluation of such controls.
     Item 308(c) of  Regulation  S-B requires you to disclose any change in your
     internal  control over financial  reporting  identified in connection  with
     your  evaluation that occurred during your last fiscal quarter (your fourth
     fiscal  quarter  in the  case of an  annual  report)  that  has  materially
     affected,  or is  reasonably  likely to  materially  affect,  your internal
     control over financial  reporting.  If true, please confirm that there were
     no changes in your internal control over financial  reporting that occurred
     during your fourth fiscal quarter of 2003 that had  materially  affected or
     was  reasonably  likely to  materially  affect your  internal  control over
     financial reporting. In addition, please confirm, if true, for the quarters
     ended March 31,  2004 and June 30,  2004 and confirm  that you will use the
     correct phrasing in your future periodic reports.

     The Company  advises  the Staff that there were no changes in its  internal
     control over  financial  reporting  that occurred  during our fourth fiscal
     quarter of 2003 and for the quarters ended March 31, 2004 and June 30, 2004
     that had materially  affected or was reasonably likely to materially affect
     our internal  control over  financial  reporting.  The Company will use the
     correct phrasing in its future periodic reports.

                    Form l0-QSB for ended September 30, 2004

Controls and Procedures

49.  We note that you cite a material weakness in your internal controls for the
     period  ended  September  30,  2004.  Please  disclose how your CEO and CFO
     concluded that your  disclosure  controls and procedures  were effective in
     light  of the  weaknesses  communicated  to  the  company  by its  auditors
     regarding the company's internal controls. Please discuss in specific terms
     the processes and  procedures  that you had in place for the period covered
     by this report that enabled the officers to reach the  conclusion  that the
     company's controls and procedures were effective.

     As noted in the  introduction  to this letter,  the Company intends to file
     its revised  Form 10-QSB as soon as it clears its  responses to the Staff's
     comments.


                                       11


50.  Please  disclose  in  more  detail  what  your  auditors  considered  to be
     weaknesses in your internal controls relating to the "inadequate  structure
     within our accounting department."

     As noted in the  introduction  to this letter,  the Company intends to file
     its revised  Form 10-QSB as soon as it clears its  responses to the Staff's
     comments.

51.  Please  discuss in detail what steps you are taking to remedy the  weakness
     in your internal controls.

     As noted in the  introduction  to this letter,  the Company intends to file
     its revised  Form 10-QSB as soon as it clears its  responses to the Staff's
     comments.

52.  We also  note  your  statement  in the  first  paragraph  that  "management
     recognized  that any controls and  procedures,  no matter how well designed
     and  operated,  can provide only  reasonable  assurance  of  achieving  the
     desired control  objectives." Please revise to state clearly, if true, that
     your chief  executive  officer and chief financial  officer  concluded that
     your  disclosure  controls and  procedures  are effective at the reasonable
     assurance level. In the  alternative,  remove the reference to the level of
     assurance  of your  disclosure  controls  and  procedures.  Please refer to
     Section II.F.4 of Management's  Reports on Internal  Control Over Financial
     Reporting and Certification of Disclosure in Exchange Act Periodic Reports,
     SEC    Release    No.    33-823    8,     available    on    our    website
     htttp://www.sec.gov/rules/final/33- 8238.htm>.

     As noted in the  introduction  to this letter,  the Company intends to file
     its revised  Form 10-QSB as soon as it clears its  responses to the Staff's
     comments.

53.  We note your  disclosure  that  "[e]xcept  as  discussed  in the  following
     paragraph,  subsequent to the date of this  evaluation,  there have been no
     significant changes in our internal controls or in other factors that could
     significantly  affect these controls."  (emphasis  added).  Revise to state
     clearly, if correct,  that there were changes in your internal control over
     financial  reporting  that  occurred  during this fiscal  quarter that have
     materially  affected,  or are reasonably likely to materially affect,  your
     internal  control over  financial  reporting,  and clearly  identify  these
     changes in your internal  control over  financial  reporting  that occurred
     during this period.

     As noted in the  introduction  to this letter,  the Company intends to file
     its revised  Form 10-QSB as soon as it clears its  responses to the Staff's
     comments.

Please contact the  undersigned at  212-981-6766  with any questions or comments
you may have with respect to the foregoing.

                                               Very truly yours,

                                               Louis A. Brilleman


                                       12